You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: May 2020 to March 2024

AbstractFullPdf
May 202014614629
Jun 202025825859
Jul 2020666622
Aug 2020515123
Sep 2020535311
Oct 2020373710
Nov 2020272712
Dec 202024246
Jan 2021454522
Feb 2021606025
Mar 2021484819
Apr 2021373714
May 2021262614
Jun 2021575718
Jul 2021535327
Aug 2021282812
Sep 2021343420
Oct 2021444439
Nov 2021282828
Dec 202131319
Jan 2022353914
Feb 202222229
Mar 202230319
Apr 202240429
May 2022404117
Jun 2022424211
Jul 202228306
Aug 2022545413
Sep 2022505114
Oct 2022394111
Nov 2022283120
Dec 202219191
Jan 202314145
Feb 2023515111
Mar 202335368
Apr 202319199
May 2023363610
Jun 202317177
Jul 2023373712
Aug 2023313110
Sep 202323239
Oct 2023252610
Nov 2023333314
Dec 2023353513
Jan 2024131412
Feb 2024292922
Mar 2024252679
Total20032023784